NCT01204918View on ClinicalTrials.gov

Efficacy and Tolerability of Riluzole in Treatment Resistant Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

May 31, 2015

Study Completion Date

August 31, 2015

Conditions
Depression
Interventions
DRUG

Riluzole

Riluzole 100mg PO

DRUG

placebo

placebo

Trial Locations (3)

77030

Baylor College of Medicine, Houston

06511

Yale University, Yale Depression Research Program, New Haven

02114

Massachussettes General Hospital, Depression Clinical and Research Center, Boston

All Listed Sponsors
lead

Yale University

OTHER

NCT01204918 - Efficacy and Tolerability of Riluzole in Treatment Resistant Depression | Biotech Hunter | Biotech Hunter